Corbus Pharmaceuticals Holdings, Inc. Liabilities Assumed
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Liabilities Assumed of $195.18 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2021-08-12
- Corbus Pharmaceuticals Holdings, Inc. liabilities assumed for the quarter ending 2020-06-30 was -$5.37K.
- Corbus Pharmaceuticals Holdings, Inc. liabilities assumed for the quarter ending 2020-03-31 was $200.55K.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month |
|---|---|---|
| 2020-06-30 | -$5.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $195.18K 10-Q · filed 2021-08-12 |
| 2020-03-31 | $200.55K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |